Skip to main content

Table 4 RNA-based analysis of equivocal ALK cases; 75% (6/8) of FISH-BL-positive cases were negative, 25% (2/8) were positive with both RNA-based methods. All FISH-BL-negative cases were ALK fusion negative with MPS and digital probe-based assay

From: RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance

Sample

IHC

FISH

Massive Parallel Sequencing (MPS) (IonTorrent)

Probe-Based Assays (NanoString)

Fusion

Fusion

3′/5′

Fusion

3′/5′

IHC-uncertain/FISH-BL-positive

 P19

±

+

–

–

–

–

 

IHC-positive/FISH-BL-positive

 P20

+

+

+

+

±

±

+

+

V3a/b

 P21

+

+

+

+

+

+

V1

IHC-negative/FISH-BL-positive

 P22

–

+

–

–

–

–

 

 P23

–

+

–

NA

–

NA

–

–

 

 P24

–

+

–

–

–

±

 

 P25

–

+

–

–

–

–

 

 P26

–

+

–

–

–

–

 

IHC-negative/FISH-BL-negative

 P27

–

–

–

–

–

–

–

–

 

 P28

–

–

–

–

–

–

 

 P29

–

–

–

–

–

–

 

 P30

–

–

–

–

–

–

 

IHC-negative/FISH-positive

 P31

–

+

–

–

–

–

 

 P32

–

+

–

–

–

–

 

 P33

–

+

–

–

–

–

 
  1. Fusion: fusion detection with amplicons/probes covering ALK fusion breakpoint; 3′/5′: fusion detection with amplicons/probes covering 3′ and 5′ end; NA: Not Analyzable; ND: Not Determined; +: fusion detected; −: fusion not detected; ±: fusion uncertain; V1: EML4_13:ALK_20; V3a: EML4_6a:ALK_20; V3b: EML4_6b:ALK_20